Karolina Elżbieta Kaczor-Urbanowicz

Dr. Karolina Elżbieta Kaczor-Urbanowicz

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2017 in Bioinformatics
Verified
Journal Article
Closed access
PDF file
KKKarolina Elżbieta Kaczor-Urbanowicz
Karolina Elżbieta Kaczor-Urbanowicz
YKYong Kim
Yong Kim
FLFeng Li
Feng Li
TGTimur Galeev
Timur Galeev
RKRob R Kitchen
Rob R Kitchen
David WongDavid Wong
David Wong
Motivation: Analysis of RNA sequencing (RNA-Seq) data in human saliva is challenging. Lack of standardization and unification of the bioinformatic procedures undermines saliva‘s diagnostic potential. Thus, it motivated us to perform this study. Results: We applied principal pipelines for bioinformatic analysis of small RNA-Seq data of saliva of 98 healthy Korean volunteers including either direct or indirect mapping of the reads to the human genome using Bowtie1. Analysis of alignments to exogenous genomes by another pipeline revealed that almost all of the reads map to bacterial genomes. Thus, salivary exRNA has fundamental properties that warrant the design of unique additional steps while performing the bioinformatic analysis. Our pipelines can serve as potential guidelines for processing of RNA-Seq data of human saliva. Availability and implementation: Processing and analysis results of the experimental data generated by the exceRpt (v4.6.3) small RNA-seq pipeline (github.gersteinlab.org/exceRpt) are available from exRNA atlas (exrna-atlas.org). Alignment to exogenous genomes and their quantification results were used in this paper for the analyses of small RNAs of exogenous origin.

23 May 2017 in Proteomics – Clinical Applications
Verified
Journal Article
Closed access
PDF file
KKKarolina Elżbieta Kaczor-Urbanowicz
Karolina Elżbieta Kaczor-Urbanowicz
ODOmer Deutsch
Omer Deutsch
BZBatia Zaks
Batia Zaks
GKGuy Krief
Guy Krief
SCStella Chaushu
Stella Chaushu
APAaron Palmon
Aaron Palmon

19 May 2018 in Journal of Clinical Periodontology
Verified
Journal Article
Closed access
PDF file
KKKarolina Elżbieta Kaczor-Urbanowicz
Karolina Elżbieta Kaczor-Urbanowicz
HTHarsh M. Trivedi
Harsh M. Trivedi
PLPatricia O. Lima
Patricia O. Lima
PCPaulo M. Camargo
Paulo M. Camargo
WGWilliam V. Giannobile
William V. Giannobile
David WongDavid Wong
David Wong

26 July 2022 in Cancers
Verified
Journal Article
Open access
PDF file
KKKarolina Elżbieta Kaczor-Urbanowicz
Karolina Elżbieta Kaczor-Urbanowicz
MSMustafa Saad
Mustafa Saad
TGTristan R. Grogan
Tristan R. Grogan
FLFeng Li
Feng Li
YHYou Jeong Heo
You Jeong Heo
YKYong Kim
Yong Kim
Gastric cancer (GC) has the fifth highest incidence among cancers and is the fourth leading cause of cancer-related death GC has predominantly a higher number of cases in certain ethnic groups such as the Korean population. GC found at an early stage is more treatable and has a higher survival rate as compared with GC found at a late stage. However, a diagnosis of GC is often delayed due to the lack of early symptoms and available screening programs in United States. Extracellular RNA (exRNA) is an emerging paradigm; exRNAs have the potential to serve as biomarkers in panels aimed at early detection of cancer. We previously reported the successful use of a panel of salivary exRNA for detecting GC in a high-prevalence Korean cohort, and that genetic changes reflected cancer-associated salivary exRNA changes. The current study is a case-control study of salivary exRNA biomarkers for detecting GC in an ethnically distinct U.S. cohort. A model constructed for the U.S. cohort combined demographic characteristics and salivary miRNA and mRNA biomarkers for GC and yielded an area under the receiver operating characteristic (ROC) curve (AUC) of 0.78. However, the constituents of this model differed from that constructed for the Korean cohort, thus, emphasizing the importance of population-specific biomarker development and validation.

17 February 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
MFMilan Fiala
Milan Fiala
BHBruce D Hammock
Bruce D Hammock
SHSung Hee Hwang
Sung Hee Hwang
Julian WhiteleggeJulian Whitelegge
Julian Whitelegge
KPKetema Paul
Ketema Paul
SKSantosh Kesari
Santosh Kesari
Background: Alzheimer's disease (AD) and its monoclonal antibody therapies are associated with brain vasculitis and amyloid-related imaging abnormalities. The naturally-formed epoxides (EpFAs) of polyunsaturated fatty acids (PUFAs), such as 11,12-epoxyeicosatetraenoic acid (EEQ), are anti-inflammatory and pro-resolution mediators, which are increased by dietary supplementation with ω-3 PUFAs. EpFAs are, however, enzymatically hydrolyzed by soluble epoxide hydrolase (sEH) in AD patients' macrophages in vivo and in vitro . Objective: To repair amyloid-β 1-42 (Aβ) degradation by AD macrophages using the inhibitors of a) soluble epoxide hydrolase (sEHIs), termed TPPU and EC5026, together with EpFAs, or b) STING pathway termed H-151. Methods: Immunobiology, immunochemistry, RNA sequencing, and confocal microscopy were used. Results: In AD brain (examined postmortem), monocyte/macrophages upload Aβ in plaques and transfer it without degradation into brain microvessels, suffer apoptotis, and release Aβ, inducing vasculitis. The EpFAs of epoxyeicosatetraenoic acid (EEQ), along with the inhibitors TPPU and H-151, decrease inflammatory cytokines and regulate macrophage unfolded protein response to endoplasmic reticulum stress. Treatment of AD macrophages by TPPU with EEQ or by STING inhibitor H-151 increased uploading of Aβ after 2 hours and increased degradation of Aβ after 24 hours. Conclusions: The sEHI inhibitor EC5026 and the STING inhibitor H-151 increased macrophage uptake and degradation of Aβ. EC5026 administration was safe in normal volunteers. EC5026 together with ω-3 PUFA supplementation are indicated for in a clinical trial in patients with mild cognitive impairment.